Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Abstract Text:

Kimberly C Kirby,Lois A Benishek,Karen Leggett Dugosh,Marylouise E Kerwin,

Contingency management (CM) interventions are among the most effective methods for initiating drug abstinence, but they infrequently have been adopted by community drug and alcohol treatment programs. The primary purpose of this investigation was to determine the prevalence of specific beliefs that community treatment providers hold regarding contingency management interventions. We surveyed 383 treatment providers from three geographical areas of the United States regarding moral or ethical objections, negative side effects, practicality, limitations and positive opinions regarding tangible and social CM interventions. Results indicate that positive beliefs were surprisingly prevalent, with providers agreeing with an average of 67% of the positive statements regarding CM using tangible incentives and 54% indicating that they would be in favor of adding a tangible CM intervention to their treatment program. The most prevalent objections to incentive programs were that they cost too much, fail to address the underlying problems of addiction, and do not address multiple behaviors. Social incentives were viewed more favorably than tangible incentives and both were viewed more positively by providers who were supervisors, had advanced degrees, had more addictions experience, and had previous experience with tangible incentives. These findings have implications for improving the dissemination of this empirically-supported treatment.

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Publishing Authors By Initials

KC Kirby,LA Benishek,KL Dugosh,ME Kerwin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Drug and alcohol dependence

VOLUME: 85

Page Numbers: 19-27

Journal Abbreviation:

ISSN: 0376-8716

DAY: 2

MONTH: 05

YEAR: 2006

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7513587

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.

AFFILIATION: Treatment Research Institute, 600 Public Ledger Building, 150 S. Independence Mall West, Philadelphia, PA 19106, USA. kkirby@tresearch.org

Country: Ireland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Drug Alcohol Depend

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination Related Publications

• A faith-based intervention for cocaine-dependent Black women.
• An analytical examination of muscle force estimations using optimization techniques.
• Biological determinants of difficult to treat patients with schizophrenia.
• Cardiac alert: decreasing door-to-balloon time for ST elevation myocardial infarction.
• Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography.
• Coupling reactions of bromoalkynes with imidazoles mediated by copper salts: synthesis of novel N-alkynylimidazoles.
• Enediynes from aza-enediynes: C,N-dialkynyl imines undergo both aza-Bergman rearrangement and conversion to enediynes and fumaronitriles.
• Identification of the adduct between a 4-Aza-3-ene-1,6-diyne and DNA using electrospray ionization mass spectrometry.
• Musculoskeletal demands of progressions for the longswing on high bar.
• Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
• Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia.
• Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography.
• Serotonergic polymorphisms and psychotic disorders in populations from North Spain.
• Simian Virus 40 Large T-Antigen G-Quadruplex DNA Helicase Inhibition by G-Quadruplex DNA-Interactive Agents.
• Some aspects of coronary atherosclerosis and its sequelae.
• Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.
• Synthesis, metal ion binding, and biological evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1.